Publication | Closed Access

Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors

UrologySurgical OncologyGenitourinary CancerMedicineCisplatin-refractory And/or MultiplyLong-term SurvivalSurgeryGerm Cell TumorsCancer TreatmentOncology